miR-296 Regulates Growth Factor Receptor Overexpression in Angiogenic Endothelial Cells

Cancer Cell - Tập 14 Số 5 - Trang 382-393 - 2008
Thomas Würdinger1,2,3, Cathy Tournier1,2, Okay Saydam2, Johan Skog2, Stephan Grau4, Jürgen Soutschek5, Ralph Weissleder1,6, Xandra O. Breakefield1,2, Anna M. Krichevsky7
1Center for Molecular Imaging Research, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02115, USA
2Department of Neurology and Department of Radiology, Massachusetts General Hospital and Neuroscience Program, Harvard Medical School, Boston, MA 02115, USA
3Neuro-oncology Research Group, Department of Neurosurgery, VU Medical Center, Cancer Center Amsterdam, 1007 MB Amsterdam, The Netherlands
4Department of Neurosurgery, Klinikum Grosshadern, Ludwig-Maximilians-University Munich, 80539 Munich, Germany
5Regulus Therapeutics, Carlsbad, CA 92008, USA
6Center for Systems Biology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02115, USA
7Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115 USA

Tóm tắt

Từ khóa


Tài liệu tham khảo

Ambros, 2004, The functions of animal microRNAs, Nature, 431, 350, 10.1038/nature02871

Bache, 2003, STAM and Hrs are subunits of a multivalent ubiquitin-binding complex on early endosomes, J. Biol. Chem., 278, 12513, 10.1074/jbc.M210843200

Bartel, 2004, MicroRNAs: genomics, biogenesis, mechanism, and function, Cell, 116, 281, 10.1016/S0092-8674(04)00045-5

Batchelor, 2007, AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients, Cancer Cell, 11, 83, 10.1016/j.ccr.2006.11.021

Brem, 1972, Tumor angiogenesis: a quantitative method for histologic grading, J. Natl. Cancer Inst., 48, 347

Calin, 2006, MicroRNA signatures in human cancers, Nat. Rev. Cancer, 6, 857, 10.1038/nrc1997

Chen, 2008, Soluble CD40 ligand induces endothelial dysfunction in human and porcine coronary artery endothelial cells, Blood, 112, 3205, 10.1182/blood-2008-03-143479

de Fougerolles, 2007, Interfering with disease: a progress report on siRNA-based therapeutics, Nat. Rev. Drug Discov., 6, 443, 10.1038/nrd2310

Dews, 2006, Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster, Nat. Genet., 38, 1060, 10.1038/ng1855

Esquela-Kerscher, 2006, Oncomirs - microRNAs with a role in cancer, Nat. Rev. Cancer, 6, 259, 10.1038/nrc1840

Ewan, 2006, Intrinsic tyrosine kinase activity is required for vascular endothelial growth factor receptor 2 ubiquitination, sorting and degradation in endothelial cells, Traffic, 7, 1270, 10.1111/j.1600-0854.2006.00462.x

Fish, 2008, miR-126 regulates angiogenic signaling and vascular integrity, Dev. Cell, 15, 272, 10.1016/j.devcel.2008.07.008

Folkerth, 2000, Descriptive analysis and quantification of angiogenesis in human brain tumors, J. Neurooncol., 50, 165, 10.1023/A:1006499824379

Folkman, 2007, Angiogenesis: an organizing principle for drug discovery?, Nat. Rev. Drug Discov., 6, 273, 10.1038/nrd2115

Griffiths-Jones, 2006, miRBase: microRNA sequences, targets and gene nomenclature, Nucleic Acids Res., 34, D140, 10.1093/nar/gkj112

Grimm, 2005, Use of gene expression profiling to direct in vivo molecular imaging of lung cancer, Proc. Natl. Acad. Sci. USA, 102, 14404, 10.1073/pnas.0503920102

Haglund, 2003, Multiple monoubiquitination of RTKs is sufficient for their endocytosis and degradation, Nat. Cell Biol., 5, 461, 10.1038/ncb983

Jackson, 2003, Expression profiling reveals off-target gene regulation by RNAi, Nat. Biotechnol., 21, 635, 10.1038/nbt831

Jain, 2005, Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy, Science, 307, 58, 10.1126/science.1104819

John, 2004, Human MicroRNA targets, PLoS Biol., 2, e363, 10.1371/journal.pbio.0020363

Kerbel, 2002, Clinical translation of angiogenesis inhibitors, Nat. Rev. Cancer, 2, 727, 10.1038/nrc905

Khodarev, 2003, Tumour-endothelium interactions in co-culture: coordinated changes of gene expression profiles and phenotypic properties of endothelial cells, J. Cell Sci., 116, 1013, 10.1242/jcs.00281

Kloosterman, 2006, The diverse functions of microRNAs in animal development and disease, Dev. Cell, 11, 441, 10.1016/j.devcel.2006.09.009

Krek, 2005, Combinatorial microRNA target predictions, Nat. Genet., 37, 495, 10.1038/ng1536

Krichevsky, 2003, A microRNA array reveals extensive regulation of microRNAs during brain development, RNA, 9, 1274, 10.1261/rna.5980303

Krutzfeldt, 2005, Silencing of microRNAs in vivo with ‘antagomirs’, Nature, 438, 685, 10.1038/nature04303

Kuehbacher, 2007, Role of Dicer and Drosha for endothelial microRNA expression and angiogenesis, Circ. Res., 101, 59, 10.1161/CIRCRESAHA.107.153916

Lee, 2007, MicroRNA-378 promotes cell survival, tumor growth, and angiogenesis by targeting SuFu and Fus-1 expression, Proc. Natl. Acad. Sci. USA, 104, 20350, 10.1073/pnas.0706901104

Lewis, 2005, Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets, Cell, 120, 15, 10.1016/j.cell.2004.12.035

Miebach, 2006, Isolation and culture of microvascular endothelial cells from gliomas of different WHO grades, J. Neurooncol., 76, 39, 10.1007/s11060-005-3674-6

Miranda, 2006, A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes, Cell, 126, 1203, 10.1016/j.cell.2006.07.031

Montet, 2005, Tomographic fluorescence mapping of tumor targets, Cancer Res., 65, 6330, 10.1158/0008-5472.CAN-05-0382

Montet, 2007, Tomographic fluorescence imaging of tumor vascular volume in mice, Radiology, 242, 751, 10.1148/radiol.2423052065

Ntziachristos, 2002, Fluorescence molecular tomography resolves protease activity in vivo, Nat. Med., 8, 757, 10.1038/nm729

Poliseno, 2006, MicroRNAs modulate the angiogenic properties of HUVECs, Blood, 108, 3068, 10.1182/blood-2006-01-012369

Raiborg, 2002, Hrs sorts ubiquitinated proteins into clathrin-coated microdomains of early endosomes, Nat. Cell Biol., 4, 394, 10.1038/ncb791

Reich, 2003, Small interfering RNA (siRNA) targeting VEGF effectively inhibits ocular neovascularization in a mouse model, Mol. Vis., 9, 210

Rizzo, 2004, An improved cyan fluorescent protein variant useful for FRET, Nat. Biotechnol., 22, 445, 10.1038/nbt945

Ruvkun, 2006, Clarifications on miRNA and cancer, Science, 311, 36, 10.1126/science.311.5757.36d

Shen, 2006, Suppression of ocular neovascularization with siRNA targeting VEGF receptor 1, Gene Ther., 13, 225, 10.1038/sj.gt.3302641

Shih, 2006, Platelet-derived growth factor (PDGF) and glial tumorigenesis, Cancer Lett., 232, 139, 10.1016/j.canlet.2005.02.002

Stern, 2007, Epidermal growth factor receptor fate is controlled by Hrs tyrosine phosphorylation sites that regulate Hrs degradation, Mol. Cell. Biol., 27, 888, 10.1128/MCB.02356-05

Suárez, 2007, Dicer dependent microRNAs regulate gene expression and functions in human endothelial cells, Circ. Res., 100, 1164, 10.1161/01.RES.0000265065.26744.17

Takata, 2000, A hrs binding protein having a Src homology 3 domain is involved in intracellular degradation of growth factors and their receptors, Genes Cells, 5, 57, 10.1046/j.1365-2443.2000.00303.x

Tuccoli, 2006, miRNAs regulate miRNAs: coordinated transcriptional and post-transcriptional regulation, Cell Cycle, 5, 2473, 10.4161/cc.5.21.3422

Wang, 2008, The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis, Dev. Cell, 15, 261, 10.1016/j.devcel.2008.07.002

Wurdinger, 2007, Molecular therapy in the microRNA era, Pharmacogenomics J., 7, 297, 10.1038/sj.tpj.6500429